GV20 ONCOTHERAPY
GV20 ONCOTHERAPY
Social Links:
Industry:
Big Data Health Care
Founded:
2016-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.bioxbh.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.9 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Euro Apache 2.4 Ubuntu Japanese Yen Alibaba HiChina DNS
Similar Organizations
Doctor Anywhere
Doctor Anywhere is a telehealth company .
Healios
The UK’s leading digital healthcare company .
Lyvgen Biopharma
Lyvgen Biopharma is a Healthcare Company.
StanPlus
A Health And Healthcare Company.
Current Employees Featured
Founder
Investors List
Watson Capital Partners
Watson Capital Partners investment in Series B - GV20 Oncotherapy
Linear Capital Partners
Linear Capital Partners investment in Series B - GV20 Oncotherapy
Coatue
Coatue investment in Series B - GV20 Oncotherapy
3W Fund Management
3W Fund Management investment in Series B - GV20 Oncotherapy
IDG Capital
IDG Capital investment in Series B - GV20 Oncotherapy
IDG Capital
IDG Capital investment in Angel Round - GV20 Oncotherapy
Linear Venture
Linear Venture investment in Angel Round - GV20 Oncotherapy
Watson Investment
Watson Investment investment in Angel Round - GV20 Oncotherapy
Official Site Inspections
http://www.bioxbh.com
- Host name: 120.78.74.7
- IP address: 120.78.74.7
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "GV20 Oncotherapy"
GV20
We utilize high throughput functional genomics and AI approaches to identify novel cancer immunology drug targets, and discover and develop effective antibody drugs in cancer. …See details»
GV20 Therapeutics - Crunchbase Company Profile
Contact Email [email protected] GV20 Therapeutics is a cancer immunology drug discovery and development company that uses high throughput …See details»
GV20 Therapeutics - Team - bioxbh.com
We utilize high throughput functional genomics and AI approaches to identify novel cancer immunology drug targets, and discover and develop effective antibody drugs in cancer. …See details»
GV20 - bioxbh.com
We utilize high throughput functional genomics and AI approaches to identify novel cancer immunology drug targets, and discover and develop effective antibody drugs in cancer. …See details»
GV20 Oncotherapy - PitchBook
GV20 Oncotherapy General Information Description. Developer of medical biotechnologies intended for customized cancer treatment. The company focuses on leveraging gene editing and bioinformatics technologies to find targets for …See details»
GV20 Oncotherapy Overview | SignalHire Company Profile
GV20 Oncotherapy headquarters is in Cambridge, Massachusetts. GV20 Oncotherapy is in the sectors of: Pharma. To connect with GV20 Oncotherapy's employee register on SignalHireSee details»
GV20 Oncotherapy - Golden
GV20 Oncotherapy is an antibody for Cancer founded in 2016 by Shirley Liu. Overview Structured Data Issues Contributors Activity. ContentsSee details»
Ozmosi | XBH-40 Drug Profile
GV20 Therapeutics is developing XBH-40, a driver and marker of multiple cancer types in Immuno-Oncology.See details»
寻百会-动脉网 - vbdata.cn
Jul 21, 2016 寻百会是一家在肿瘤免疫治疗新靶点发现和抗体药物开发领域拥有独特技术的创新药公司。寻百会生物依托美国哈佛大学刘小乐教授实验室 CRISPR 全基因组筛选的先进技术， …See details»
Shanghai Xunbaihui Biotechnology - Company Profile - Tracxn
Nov 19, 2024 Shanghai Xunbaihui Biotechnology ranks 84th among 588 active competitors. 68 of its competitors are funded while 62 have exited. Overall, Shanghai Xunbaihui Biotechnology …See details»
上海寻百会生物科技有限公司_寻百会 - qydb.leshanvc.com
上海寻百会生物科技有限公司（以下简称「寻百会生物」）于 2016 年 7 月创立于张江药谷孵化器，是一家致力于通过整合基因组学、生物信息方法来筛选癌症药物的有效靶点，并开发有效的 …See details»
BIOX Corporation Information - RocketReach
We are a renewable energy company that designed, built, owns and operates a 67 million litre per annum nameplate capacity biodiesel production facility in Hamilton, Ontario Canada.See details»
The GV20 STEAD Platform - bioxbh.com
We utilize high throughput functional genomics and AI approaches to identify novel cancer immunology drug targets, and discover and develop effective antibody drugs in cancer. …See details»
Wei Li - Google Scholar
Children's National Hospital, George Washington University - Cited by 9,900 - Computational Biology - Algorithm - Functional Genomics - Cancer - Genome EngineeringSee details»
Myles Brown - Google Scholar
Emil Frei III Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical School - Cited by 83,934 - Epigenetics - transcription - steroid receptors - hormone dependent cancer - …See details»
BIOX Corporation Careers and Employment | Indeed.com
Mar 5, 2017 Find out what works well at BIOX Corporation from the people who know best. Get the inside scoop on jobs, salaries, top office locations, and CEO insights. Compare pay for …See details»
Bioxbio - Overview, News & Similar companies | ZoomInfo.com
View Bioxbio (www.bioxbio.com) location in United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Biohax - Your Online Biohacking Solution
Unlock your genetic potential with Biohax Institute: your go-to for data-driven biohacking. Achieve peak performance with personalized therapeutics based on advanced lab testing.See details»
XBH-82 Drug Profile - Ozmosi
GV20 Therapeutics is developing the first in class XBH-82 for Immuno-Oncology.See details»
BioBX - Crunchbase Company Profile & Funding
BioBX manufactures and sells safe, effective nutraceuticals, and dietary supplements for the mass market.See details»